nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—ALB—lung cancer	0.292	1	CbGaD
Cefazolin—ALB—Gefitinib—lung cancer	0.0782	0.208	CbGbCtD
Cefazolin—SLC22A11—Methotrexate—lung cancer	0.064	0.171	CbGbCtD
Cefazolin—ABCC4—Methotrexate—lung cancer	0.0596	0.159	CbGbCtD
Cefazolin—ALB—Erlotinib—lung cancer	0.0462	0.123	CbGbCtD
Cefazolin—ALB—Irinotecan—lung cancer	0.0417	0.111	CbGbCtD
Cefazolin—SLC22A8—Methotrexate—lung cancer	0.0372	0.0993	CbGbCtD
Cefazolin—SLC22A6—Methotrexate—lung cancer	0.0259	0.0692	CbGbCtD
Cefazolin—ALB—Methotrexate—lung cancer	0.0221	0.0589	CbGbCtD
Cefazolin—Cefotetan—ALB—lung cancer	0.000493	0.214	CrCbGaD
Cefazolin—Cefpiramide—ALB—lung cancer	0.000429	0.186	CrCbGaD
Cefazolin—Cefonicid—ALB—lung cancer	0.000374	0.162	CrCbGaD
Cefazolin—Cefmetazole—ALB—lung cancer	0.000329	0.143	CrCbGaD
Cefazolin—Vomiting—Vinblastine—lung cancer	0.000228	0.000975	CcSEcCtD
Cefazolin—Dizziness—Erlotinib—lung cancer	0.000228	0.000974	CcSEcCtD
Cefazolin—Anaemia—Paclitaxel—lung cancer	0.000227	0.00097	CcSEcCtD
Cefazolin—Erythema multiforme—Docetaxel—lung cancer	0.000226	0.000967	CcSEcCtD
Cefazolin—Agitation—Paclitaxel—lung cancer	0.000225	0.000965	CcSEcCtD
Cefazolin—Headache—Vinblastine—lung cancer	0.000224	0.00096	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.000224	0.000959	CcSEcCtD
Cefazolin—Leukopenia—Etoposide—lung cancer	0.000224	0.000959	CcSEcCtD
Cefazolin—Hypotension—Gemcitabine—lung cancer	0.000223	0.000956	CcSEcCtD
Cefazolin—Anaphylactic shock—Cisplatin—lung cancer	0.000223	0.000954	CcSEcCtD
Cefazolin—Vomiting—Topotecan—lung cancer	0.000221	0.000947	CcSEcCtD
Cefazolin—Cefoperazone—ALB—lung cancer	0.00022	0.0956	CrCbGaD
Cefazolin—Syncope—Paclitaxel—lung cancer	0.00022	0.000942	CcSEcCtD
Cefazolin—Loss of consciousness—Etoposide—lung cancer	0.00022	0.000941	CcSEcCtD
Cefazolin—Leukopenia—Paclitaxel—lung cancer	0.00022	0.00094	CcSEcCtD
Cefazolin—Rash—Topotecan—lung cancer	0.000219	0.000939	CcSEcCtD
Cefazolin—Hypersensitivity—Vinorelbine—lung cancer	0.000219	0.000939	CcSEcCtD
Cefazolin—Dermatitis—Topotecan—lung cancer	0.000219	0.000938	CcSEcCtD
Cefazolin—Vomiting—Erlotinib—lung cancer	0.000219	0.000937	CcSEcCtD
Cefazolin—Somnolence—Irinotecan—lung cancer	0.000218	0.000934	CcSEcCtD
Cefazolin—Thrombocytopenia—Cisplatin—lung cancer	0.000218	0.000934	CcSEcCtD
Cefazolin—Headache—Topotecan—lung cancer	0.000218	0.000933	CcSEcCtD
Cefazolin—Rash—Erlotinib—lung cancer	0.000217	0.000929	CcSEcCtD
Cefazolin—Dermatitis—Erlotinib—lung cancer	0.000217	0.000928	CcSEcCtD
Cefazolin—Convulsion—Etoposide—lung cancer	0.000217	0.000928	CcSEcCtD
Cefazolin—Dyspepsia—Irinotecan—lung cancer	0.000216	0.000925	CcSEcCtD
Cefazolin—Headache—Erlotinib—lung cancer	0.000216	0.000923	CcSEcCtD
Cefazolin—Loss of consciousness—Paclitaxel—lung cancer	0.000216	0.000923	CcSEcCtD
Cefazolin—Asthenia—Vinorelbine—lung cancer	0.000214	0.000914	CcSEcCtD
Cefazolin—Decreased appetite—Irinotecan—lung cancer	0.000213	0.000913	CcSEcCtD
Cefazolin—Eosinophilia—Methotrexate—lung cancer	0.000213	0.000911	CcSEcCtD
Cefazolin—Nausea—Vinblastine—lung cancer	0.000213	0.000911	CcSEcCtD
Cefazolin—Somnolence—Gemcitabine—lung cancer	0.000213	0.00091	CcSEcCtD
Cefazolin—Convulsion—Paclitaxel—lung cancer	0.000213	0.00091	CcSEcCtD
Cefazolin—Anorexia—Cisplatin—lung cancer	0.000212	0.000909	CcSEcCtD
Cefazolin—Fatigue—Irinotecan—lung cancer	0.000212	0.000906	CcSEcCtD
Cefazolin—Pruritus—Vinorelbine—lung cancer	0.000211	0.000901	CcSEcCtD
Cefazolin—Pain—Irinotecan—lung cancer	0.00021	0.000899	CcSEcCtD
Cefazolin—Hypotension—Cisplatin—lung cancer	0.000208	0.000891	CcSEcCtD
Cefazolin—Decreased appetite—Gemcitabine—lung cancer	0.000208	0.00089	CcSEcCtD
Cefazolin—Nausea—Topotecan—lung cancer	0.000207	0.000885	CcSEcCtD
Cefazolin—Fatigue—Gemcitabine—lung cancer	0.000206	0.000882	CcSEcCtD
Cefazolin—Confusional state—Etoposide—lung cancer	0.000206	0.000881	CcSEcCtD
Cefazolin—Pain—Gemcitabine—lung cancer	0.000204	0.000875	CcSEcCtD
Cefazolin—Nausea—Erlotinib—lung cancer	0.000204	0.000875	CcSEcCtD
Cefazolin—Pancytopenia—Methotrexate—lung cancer	0.000204	0.000874	CcSEcCtD
Cefazolin—Anaphylactic shock—Etoposide—lung cancer	0.000204	0.000874	CcSEcCtD
Cefazolin—Diarrhoea—Vinorelbine—lung cancer	0.000204	0.000872	CcSEcCtD
Cefazolin—Feeling abnormal—Irinotecan—lung cancer	0.000202	0.000866	CcSEcCtD
Cefazolin—Confusional state—Paclitaxel—lung cancer	0.000202	0.000864	CcSEcCtD
Cefazolin—Blood creatinine increased—Doxorubicin—lung cancer	0.000202	0.000864	CcSEcCtD
Cefazolin—Neutropenia—Methotrexate—lung cancer	0.000201	0.000861	CcSEcCtD
Cefazolin—Gastrointestinal pain—Irinotecan—lung cancer	0.000201	0.000859	CcSEcCtD
Cefazolin—Anaphylactic shock—Paclitaxel—lung cancer	0.0002	0.000857	CcSEcCtD
Cefazolin—Thrombocytopenia—Etoposide—lung cancer	0.0002	0.000856	CcSEcCtD
Cefazolin—Feeling abnormal—Gemcitabine—lung cancer	0.000197	0.000843	CcSEcCtD
Cefazolin—Shock—Paclitaxel—lung cancer	0.000197	0.000843	CcSEcCtD
Cefazolin—Dizziness—Vinorelbine—lung cancer	0.000197	0.000842	CcSEcCtD
Cefazolin—Abdominal pain upper—Doxorubicin—lung cancer	0.000197	0.000842	CcSEcCtD
Cefazolin—Thrombocytopenia—Paclitaxel—lung cancer	0.000196	0.000839	CcSEcCtD
Cefazolin—Anorexia—Etoposide—lung cancer	0.000195	0.000833	CcSEcCtD
Cefazolin—Abdominal pain—Irinotecan—lung cancer	0.000194	0.000831	CcSEcCtD
Cefazolin—Body temperature increased—Irinotecan—lung cancer	0.000194	0.000831	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000194	0.000831	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000194	0.000831	CcSEcCtD
Cefazolin—Decreased appetite—Cisplatin—lung cancer	0.000194	0.000829	CcSEcCtD
Cefazolin—Anaemia—Docetaxel—lung cancer	0.000192	0.000823	CcSEcCtD
Cefazolin—Anorexia—Paclitaxel—lung cancer	0.000191	0.000817	CcSEcCtD
Cefazolin—Hypotension—Etoposide—lung cancer	0.000191	0.000817	CcSEcCtD
Cefazolin—Pain—Cisplatin—lung cancer	0.000191	0.000816	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.00019	0.000814	CcSEcCtD
Cefazolin—Vomiting—Vinorelbine—lung cancer	0.000189	0.00081	CcSEcCtD
Cefazolin—Body temperature increased—Gemcitabine—lung cancer	0.000189	0.000809	CcSEcCtD
Cefazolin—Renal failure—Methotrexate—lung cancer	0.000189	0.000807	CcSEcCtD
Cefazolin—Rash—Vinorelbine—lung cancer	0.000188	0.000803	CcSEcCtD
Cefazolin—Dermatitis—Vinorelbine—lung cancer	0.000188	0.000803	CcSEcCtD
Cefazolin—Hypotension—Paclitaxel—lung cancer	0.000187	0.000801	CcSEcCtD
Cefazolin—Stomatitis—Methotrexate—lung cancer	0.000187	0.0008	CcSEcCtD
Cefazolin—Headache—Vinorelbine—lung cancer	0.000186	0.000798	CcSEcCtD
Cefazolin—Syncope—Docetaxel—lung cancer	0.000186	0.000798	CcSEcCtD
Cefazolin—Leukopenia—Docetaxel—lung cancer	0.000186	0.000797	CcSEcCtD
Cefazolin—Eosinophilia—Doxorubicin—lung cancer	0.000184	0.000789	CcSEcCtD
Cefazolin—Feeling abnormal—Cisplatin—lung cancer	0.000184	0.000786	CcSEcCtD
Cefazolin—Loss of consciousness—Docetaxel—lung cancer	0.000183	0.000782	CcSEcCtD
Cefazolin—Somnolence—Etoposide—lung cancer	0.000182	0.000777	CcSEcCtD
Cefazolin—Hypersensitivity—Irinotecan—lung cancer	0.000181	0.000774	CcSEcCtD
Cefazolin—Convulsion—Docetaxel—lung cancer	0.00018	0.000771	CcSEcCtD
Cefazolin—Agranulocytosis—Methotrexate—lung cancer	0.000179	0.000766	CcSEcCtD
Cefazolin—Somnolence—Paclitaxel—lung cancer	0.000178	0.000762	CcSEcCtD
Cefazolin—Decreased appetite—Etoposide—lung cancer	0.000178	0.00076	CcSEcCtD
Cefazolin—Pancytopenia—Doxorubicin—lung cancer	0.000177	0.000757	CcSEcCtD
Cefazolin—Nausea—Vinorelbine—lung cancer	0.000177	0.000757	CcSEcCtD
Cefazolin—Dyspepsia—Paclitaxel—lung cancer	0.000176	0.000754	CcSEcCtD
Cefazolin—Body temperature increased—Cisplatin—lung cancer	0.000176	0.000754	CcSEcCtD
Cefazolin—Asthenia—Irinotecan—lung cancer	0.000176	0.000754	CcSEcCtD
Cefazolin—Fatigue—Etoposide—lung cancer	0.000176	0.000754	CcSEcCtD
Cefazolin—Pain—Etoposide—lung cancer	0.000175	0.000747	CcSEcCtD
Cefazolin—Neutropenia—Doxorubicin—lung cancer	0.000174	0.000745	CcSEcCtD
Cefazolin—Decreased appetite—Paclitaxel—lung cancer	0.000174	0.000745	CcSEcCtD
Cefazolin—Haemoglobin—Methotrexate—lung cancer	0.000173	0.000741	CcSEcCtD
Cefazolin—Fatigue—Paclitaxel—lung cancer	0.000173	0.000739	CcSEcCtD
Cefazolin—Haemorrhage—Methotrexate—lung cancer	0.000172	0.000737	CcSEcCtD
Cefazolin—Hepatitis—Methotrexate—lung cancer	0.000172	0.000737	CcSEcCtD
Cefazolin—Ceftriaxone—ALB—lung cancer	0.000172	0.0745	CrCbGaD
Cefazolin—Asthenia—Gemcitabine—lung cancer	0.000172	0.000734	CcSEcCtD
Cefazolin—Pain—Paclitaxel—lung cancer	0.000171	0.000733	CcSEcCtD
Cefazolin—Confusional state—Docetaxel—lung cancer	0.000171	0.000732	CcSEcCtD
Cefazolin—Anaphylactic shock—Docetaxel—lung cancer	0.00017	0.000726	CcSEcCtD
Cefazolin—Pruritus—Gemcitabine—lung cancer	0.000169	0.000724	CcSEcCtD
Cefazolin—Feeling abnormal—Etoposide—lung cancer	0.000168	0.00072	CcSEcCtD
Cefazolin—Diarrhoea—Irinotecan—lung cancer	0.000168	0.000719	CcSEcCtD
Cefazolin—Gastrointestinal pain—Etoposide—lung cancer	0.000167	0.000715	CcSEcCtD
Cefazolin—Shock—Docetaxel—lung cancer	0.000167	0.000715	CcSEcCtD
Cefazolin—Thrombocytopenia—Docetaxel—lung cancer	0.000166	0.000711	CcSEcCtD
Cefazolin—Feeling abnormal—Paclitaxel—lung cancer	0.000165	0.000706	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000165	0.000705	CcSEcCtD
Cefazolin—Hypersensitivity—Cisplatin—lung cancer	0.000164	0.000703	CcSEcCtD
Cefazolin—Gastrointestinal pain—Paclitaxel—lung cancer	0.000164	0.000701	CcSEcCtD
Cefazolin—Diarrhoea—Gemcitabine—lung cancer	0.000164	0.0007	CcSEcCtD
Cefazolin—Renal failure—Doxorubicin—lung cancer	0.000163	0.000699	CcSEcCtD
Cefazolin—Erythema multiforme—Methotrexate—lung cancer	0.000163	0.000697	CcSEcCtD
Cefazolin—Dizziness—Irinotecan—lung cancer	0.000162	0.000695	CcSEcCtD
Cefazolin—Urticaria—Etoposide—lung cancer	0.000162	0.000694	CcSEcCtD
Cefazolin—Stomatitis—Doxorubicin—lung cancer	0.000162	0.000693	CcSEcCtD
Cefazolin—Anorexia—Docetaxel—lung cancer	0.000162	0.000692	CcSEcCtD
Cefazolin—Abdominal pain—Etoposide—lung cancer	0.000161	0.000691	CcSEcCtD
Cefazolin—Body temperature increased—Etoposide—lung cancer	0.000161	0.000691	CcSEcCtD
Cefazolin—Asthenia—Cisplatin—lung cancer	0.00016	0.000684	CcSEcCtD
Cefazolin—Urticaria—Paclitaxel—lung cancer	0.000159	0.000681	CcSEcCtD
Cefazolin—Hypotension—Docetaxel—lung cancer	0.000159	0.000679	CcSEcCtD
Cefazolin—Body temperature increased—Paclitaxel—lung cancer	0.000158	0.000677	CcSEcCtD
Cefazolin—Abdominal pain—Paclitaxel—lung cancer	0.000158	0.000677	CcSEcCtD
Cefazolin—Vomiting—Irinotecan—lung cancer	0.000156	0.000668	CcSEcCtD
Cefazolin—Agranulocytosis—Doxorubicin—lung cancer	0.000155	0.000663	CcSEcCtD
Cefazolin—Rash—Irinotecan—lung cancer	0.000155	0.000662	CcSEcCtD
Cefazolin—Dermatitis—Irinotecan—lung cancer	0.000155	0.000662	CcSEcCtD
Cefazolin—Headache—Irinotecan—lung cancer	0.000154	0.000658	CcSEcCtD
Cefazolin—Diarrhoea—Cisplatin—lung cancer	0.000153	0.000653	CcSEcCtD
Cefazolin—Vomiting—Gemcitabine—lung cancer	0.000152	0.000651	CcSEcCtD
Cefazolin—Somnolence—Docetaxel—lung cancer	0.000151	0.000646	CcSEcCtD
Cefazolin—Rash—Gemcitabine—lung cancer	0.000151	0.000645	CcSEcCtD
Cefazolin—Dermatitis—Gemcitabine—lung cancer	0.000151	0.000645	CcSEcCtD
Cefazolin—Hypersensitivity—Etoposide—lung cancer	0.00015	0.000644	CcSEcCtD
Cefazolin—Cefalotin—ALB—lung cancer	0.00015	0.0653	CrCbGaD
Cefazolin—Haemoglobin—Doxorubicin—lung cancer	0.00015	0.000641	CcSEcCtD
Cefazolin—Headache—Gemcitabine—lung cancer	0.00015	0.000641	CcSEcCtD
Cefazolin—Dyspepsia—Docetaxel—lung cancer	0.000149	0.000639	CcSEcCtD
Cefazolin—Haemorrhage—Doxorubicin—lung cancer	0.000149	0.000638	CcSEcCtD
Cefazolin—Hepatitis—Doxorubicin—lung cancer	0.000149	0.000638	CcSEcCtD
Cefazolin—Decreased appetite—Docetaxel—lung cancer	0.000148	0.000631	CcSEcCtD
Cefazolin—Hypersensitivity—Paclitaxel—lung cancer	0.000148	0.000631	CcSEcCtD
Cefazolin—Asthenia—Etoposide—lung cancer	0.000147	0.000627	CcSEcCtD
Cefazolin—Fatigue—Docetaxel—lung cancer	0.000146	0.000626	CcSEcCtD
Cefazolin—Nausea—Irinotecan—lung cancer	0.000146	0.000624	CcSEcCtD
Cefazolin—Pain—Docetaxel—lung cancer	0.000145	0.000621	CcSEcCtD
Cefazolin—Pruritus—Etoposide—lung cancer	0.000144	0.000618	CcSEcCtD
Cefazolin—Asthenia—Paclitaxel—lung cancer	0.000144	0.000615	CcSEcCtD
Cefazolin—Nausea—Gemcitabine—lung cancer	0.000142	0.000608	CcSEcCtD
Cefazolin—Vomiting—Cisplatin—lung cancer	0.000142	0.000607	CcSEcCtD
Cefazolin—Pruritus—Paclitaxel—lung cancer	0.000142	0.000606	CcSEcCtD
Cefazolin—Erythema multiforme—Doxorubicin—lung cancer	0.000141	0.000603	CcSEcCtD
Cefazolin—Rash—Cisplatin—lung cancer	0.000141	0.000602	CcSEcCtD
Cefazolin—Dermatitis—Cisplatin—lung cancer	0.00014	0.000601	CcSEcCtD
Cefazolin—Feeling abnormal—Docetaxel—lung cancer	0.00014	0.000599	CcSEcCtD
Cefazolin—Diarrhoea—Etoposide—lung cancer	0.00014	0.000598	CcSEcCtD
Cefazolin—Gastrointestinal pain—Docetaxel—lung cancer	0.000139	0.000594	CcSEcCtD
Cefazolin—Anaemia—Methotrexate—lung cancer	0.000139	0.000593	CcSEcCtD
Cefazolin—Diarrhoea—Paclitaxel—lung cancer	0.000137	0.000586	CcSEcCtD
Cefazolin—Cephalexin—ALB—lung cancer	0.000137	0.0593	CrCbGaD
Cefazolin—Dizziness—Etoposide—lung cancer	0.000135	0.000578	CcSEcCtD
Cefazolin—Abdominal pain—Docetaxel—lung cancer	0.000134	0.000574	CcSEcCtD
Cefazolin—Body temperature increased—Docetaxel—lung cancer	0.000134	0.000574	CcSEcCtD
Cefazolin—Leukopenia—Methotrexate—lung cancer	0.000134	0.000574	CcSEcCtD
Cefazolin—Dizziness—Paclitaxel—lung cancer	0.000132	0.000567	CcSEcCtD
Cefazolin—Nausea—Cisplatin—lung cancer	0.000132	0.000567	CcSEcCtD
Cefazolin—Convulsion—Methotrexate—lung cancer	0.00013	0.000556	CcSEcCtD
Cefazolin—Vomiting—Etoposide—lung cancer	0.00013	0.000556	CcSEcCtD
Cefazolin—Rash—Etoposide—lung cancer	0.000129	0.000551	CcSEcCtD
Cefazolin—Dermatitis—Etoposide—lung cancer	0.000129	0.000551	CcSEcCtD
Cefazolin—Headache—Etoposide—lung cancer	0.000128	0.000548	CcSEcCtD
Cefazolin—Flatulence—Doxorubicin—lung cancer	0.000128	0.000547	CcSEcCtD
Cefazolin—Vomiting—Paclitaxel—lung cancer	0.000127	0.000545	CcSEcCtD
Cefazolin—Rash—Paclitaxel—lung cancer	0.000126	0.00054	CcSEcCtD
Cefazolin—Dermatitis—Paclitaxel—lung cancer	0.000126	0.00054	CcSEcCtD
Cefazolin—Headache—Paclitaxel—lung cancer	0.000125	0.000537	CcSEcCtD
Cefazolin—Hypersensitivity—Docetaxel—lung cancer	0.000125	0.000535	CcSEcCtD
Cefazolin—Confusional state—Methotrexate—lung cancer	0.000123	0.000528	CcSEcCtD
Cefazolin—Anaphylactic shock—Methotrexate—lung cancer	0.000122	0.000524	CcSEcCtD
Cefazolin—Asthenia—Docetaxel—lung cancer	0.000122	0.000521	CcSEcCtD
Cefazolin—Nausea—Etoposide—lung cancer	0.000121	0.000519	CcSEcCtD
Cefazolin—Pruritus—Docetaxel—lung cancer	0.00012	0.000514	CcSEcCtD
Cefazolin—Anaemia—Doxorubicin—lung cancer	0.00012	0.000513	CcSEcCtD
Cefazolin—Thrombocytopenia—Methotrexate—lung cancer	0.00012	0.000513	CcSEcCtD
Cefazolin—Agitation—Doxorubicin—lung cancer	0.000119	0.00051	CcSEcCtD
Cefazolin—Nausea—Paclitaxel—lung cancer	0.000119	0.000509	CcSEcCtD
Cefazolin—Anorexia—Methotrexate—lung cancer	0.000117	0.000499	CcSEcCtD
Cefazolin—Syncope—Doxorubicin—lung cancer	0.000116	0.000498	CcSEcCtD
Cefazolin—Leukopenia—Doxorubicin—lung cancer	0.000116	0.000497	CcSEcCtD
Cefazolin—Diarrhoea—Docetaxel—lung cancer	0.000116	0.000497	CcSEcCtD
Cefazolin—Hypotension—Methotrexate—lung cancer	0.000114	0.000489	CcSEcCtD
Cefazolin—Loss of consciousness—Doxorubicin—lung cancer	0.000114	0.000488	CcSEcCtD
Cefazolin—Convulsion—Doxorubicin—lung cancer	0.000112	0.000481	CcSEcCtD
Cefazolin—Dizziness—Docetaxel—lung cancer	0.000112	0.00048	CcSEcCtD
Cefazolin—Somnolence—Methotrexate—lung cancer	0.000109	0.000465	CcSEcCtD
Cefazolin—Vomiting—Docetaxel—lung cancer	0.000108	0.000462	CcSEcCtD
Cefazolin—Dyspepsia—Methotrexate—lung cancer	0.000108	0.000461	CcSEcCtD
Cefazolin—Rash—Docetaxel—lung cancer	0.000107	0.000458	CcSEcCtD
Cefazolin—Dermatitis—Docetaxel—lung cancer	0.000107	0.000458	CcSEcCtD
Cefazolin—Confusional state—Doxorubicin—lung cancer	0.000107	0.000457	CcSEcCtD
Cefazolin—Decreased appetite—Methotrexate—lung cancer	0.000106	0.000455	CcSEcCtD
Cefazolin—Headache—Docetaxel—lung cancer	0.000106	0.000455	CcSEcCtD
Cefazolin—Anaphylactic shock—Doxorubicin—lung cancer	0.000106	0.000453	CcSEcCtD
Cefazolin—Fatigue—Methotrexate—lung cancer	0.000105	0.000451	CcSEcCtD
Cefazolin—Pain—Methotrexate—lung cancer	0.000105	0.000448	CcSEcCtD
Cefazolin—Shock—Doxorubicin—lung cancer	0.000104	0.000446	CcSEcCtD
Cefazolin—Thrombocytopenia—Doxorubicin—lung cancer	0.000104	0.000444	CcSEcCtD
Cefazolin—Anorexia—Doxorubicin—lung cancer	0.000101	0.000432	CcSEcCtD
Cefazolin—Nausea—Docetaxel—lung cancer	0.000101	0.000431	CcSEcCtD
Cefazolin—Feeling abnormal—Methotrexate—lung cancer	0.000101	0.000431	CcSEcCtD
Cefazolin—Gastrointestinal pain—Methotrexate—lung cancer	0.0001	0.000428	CcSEcCtD
Cefazolin—Hypotension—Doxorubicin—lung cancer	9.9e-05	0.000424	CcSEcCtD
Cefazolin—Urticaria—Methotrexate—lung cancer	9.72e-05	0.000416	CcSEcCtD
Cefazolin—Body temperature increased—Methotrexate—lung cancer	9.67e-05	0.000414	CcSEcCtD
Cefazolin—Abdominal pain—Methotrexate—lung cancer	9.67e-05	0.000414	CcSEcCtD
Cefazolin—Somnolence—Doxorubicin—lung cancer	9.42e-05	0.000403	CcSEcCtD
Cefazolin—Dyspepsia—Doxorubicin—lung cancer	9.32e-05	0.000399	CcSEcCtD
Cefazolin—Decreased appetite—Doxorubicin—lung cancer	9.21e-05	0.000394	CcSEcCtD
Cefazolin—ABCC4—Hemostasis—PPP2R1B—lung cancer	9.16e-05	0.000941	CbGpPWpGaD
Cefazolin—Fatigue—Doxorubicin—lung cancer	9.13e-05	0.000391	CcSEcCtD
Cefazolin—Pain—Doxorubicin—lung cancer	9.06e-05	0.000388	CcSEcCtD
Cefazolin—ABCC4—Transmembrane transport of small molecules—GNG11—lung cancer	9.05e-05	0.000929	CbGpPWpGaD
Cefazolin—Hypersensitivity—Methotrexate—lung cancer	9.01e-05	0.000386	CcSEcCtD
Cefazolin—TPMT—Metabolism—GSTT1—lung cancer	9e-05	0.000924	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—APOA1—lung cancer	8.99e-05	0.000923	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—AVP—lung cancer	8.98e-05	0.000922	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GCLC—lung cancer	8.9e-05	0.000914	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP2A6—lung cancer	8.9e-05	0.000914	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PPIA—lung cancer	8.81e-05	0.000904	CbGpPWpGaD
Cefazolin—Asthenia—Methotrexate—lung cancer	8.78e-05	0.000376	CcSEcCtD
Cefazolin—ABCC4—Hemostasis—TF—lung cancer	8.74e-05	0.000897	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—ALDOA—lung cancer	8.74e-05	0.000897	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—VEGFC—lung cancer	8.74e-05	0.000897	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—lung cancer	8.73e-05	0.000897	CbGpPWpGaD
Cefazolin—Feeling abnormal—Doxorubicin—lung cancer	8.73e-05	0.000374	CcSEcCtD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ABCC3—lung cancer	8.69e-05	0.000892	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	8.67e-05	0.00089	CbGpPWpGaD
Cefazolin—Gastrointestinal pain—Doxorubicin—lung cancer	8.66e-05	0.000371	CcSEcCtD
Cefazolin—Pruritus—Methotrexate—lung cancer	8.65e-05	0.00037	CcSEcCtD
Cefazolin—ABCC4—Hemostasis—IRF1—lung cancer	8.55e-05	0.000878	CbGpPWpGaD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—ALB—lung cancer	8.55e-05	0.000878	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—APOA1—lung cancer	8.5e-05	0.000872	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ABCG2—lung cancer	8.49e-05	0.000871	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ADCY1—lung cancer	8.49e-05	0.000871	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ENO1—lung cancer	8.44e-05	0.000866	CbGpPWpGaD
Cefazolin—Urticaria—Doxorubicin—lung cancer	8.41e-05	0.00036	CcSEcCtD
Cefazolin—ALB—Hemostasis—KIF5B—lung cancer	8.38e-05	0.000861	CbGpPWpGaD
Cefazolin—Abdominal pain—Doxorubicin—lung cancer	8.37e-05	0.000358	CcSEcCtD
Cefazolin—Body temperature increased—Doxorubicin—lung cancer	8.37e-05	0.000358	CcSEcCtD
Cefazolin—Diarrhoea—Methotrexate—lung cancer	8.37e-05	0.000358	CcSEcCtD
Cefazolin—ALB—Platelet degranulation—EGF—lung cancer	8.27e-05	0.000849	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—lung cancer	8.2e-05	0.000842	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ADCY1—lung cancer	8.14e-05	0.000836	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ABCG2—lung cancer	8.14e-05	0.000836	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—EGF—lung cancer	8.11e-05	0.000833	CbGpPWpGaD
Cefazolin—Dizziness—Methotrexate—lung cancer	8.09e-05	0.000346	CcSEcCtD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—TF—lung cancer	7.89e-05	0.00081	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—EGF—lung cancer	7.88e-05	0.000809	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—GNG11—lung cancer	7.88e-05	0.000809	CbGpPWpGaD
Cefazolin—Hypersensitivity—Doxorubicin—lung cancer	7.8e-05	0.000334	CcSEcCtD
Cefazolin—ABCC4—Hemostasis—APP—lung cancer	7.79e-05	0.0008	CbGpPWpGaD
Cefazolin—Vomiting—Methotrexate—lung cancer	7.78e-05	0.000333	CcSEcCtD
Cefazolin—Rash—Methotrexate—lung cancer	7.71e-05	0.00033	CcSEcCtD
Cefazolin—Dermatitis—Methotrexate—lung cancer	7.7e-05	0.00033	CcSEcCtD
Cefazolin—ALB—Platelet activation, signaling and aggregation—TF—lung cancer	7.67e-05	0.000788	CbGpPWpGaD
Cefazolin—Headache—Methotrexate—lung cancer	7.66e-05	0.000328	CcSEcCtD
Cefazolin—Asthenia—Doxorubicin—lung cancer	7.6e-05	0.000325	CcSEcCtD
Cefazolin—TPMT—Metabolism—CYP2E1—lung cancer	7.57e-05	0.000777	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—TF—lung cancer	7.57e-05	0.000777	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC22A18—lung cancer	7.54e-05	0.000774	CbGpPWpGaD
Cefazolin—Pruritus—Doxorubicin—lung cancer	7.49e-05	0.000321	CcSEcCtD
Cefazolin—TPMT—Metabolism—NQO1—lung cancer	7.48e-05	0.000768	CbGpPWpGaD
Cefazolin—Nausea—Methotrexate—lung cancer	7.27e-05	0.000311	CcSEcCtD
Cefazolin—Diarrhoea—Doxorubicin—lung cancer	7.25e-05	0.00031	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—lung cancer	7.21e-05	0.000741	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—AVP—lung cancer	7.17e-05	0.000736	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—ALB—lung cancer	7.12e-05	0.000731	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ABCG2—lung cancer	7.08e-05	0.000727	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ADCY1—lung cancer	7.08e-05	0.000727	CbGpPWpGaD
Cefazolin—Dizziness—Doxorubicin—lung cancer	7e-05	0.0003	CcSEcCtD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ABCB1—lung cancer	6.95e-05	0.000713	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—KDM1A—lung cancer	6.89e-05	0.000707	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL2—lung cancer	6.87e-05	0.000705	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—APP—lung cancer	6.84e-05	0.000702	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—STK11—lung cancer	6.75e-05	0.000693	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	6.74e-05	0.000692	CbGpPWpGaD
Cefazolin—Vomiting—Doxorubicin—lung cancer	6.73e-05	0.000288	CcSEcCtD
Cefazolin—Rash—Doxorubicin—lung cancer	6.68e-05	0.000286	CcSEcCtD
Cefazolin—Dermatitis—Doxorubicin—lung cancer	6.67e-05	0.000286	CcSEcCtD
Cefazolin—Headache—Doxorubicin—lung cancer	6.63e-05	0.000284	CcSEcCtD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—TF—lung cancer	6.59e-05	0.000676	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—MYC—lung cancer	6.58e-05	0.000676	CbGpPWpGaD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—ALB—lung cancer	6.52e-05	0.00067	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—RAF1—lung cancer	6.44e-05	0.000661	CbGpPWpGaD
Cefazolin—Nausea—Doxorubicin—lung cancer	6.29e-05	0.000269	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	6.29e-05	0.000645	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTP1—lung cancer	6.24e-05	0.000641	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ITGB1—lung cancer	6.23e-05	0.000639	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CAT—lung cancer	6.07e-05	0.000624	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ABCB1—lung cancer	5.91e-05	0.000607	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—PTGS2—lung cancer	5.89e-05	0.000605	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—TYMS—lung cancer	5.8e-05	0.000596	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—IL2—lung cancer	5.77e-05	0.000593	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CD9—lung cancer	5.77e-05	0.000592	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTM1—lung cancer	5.74e-05	0.000589	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—APOA1—lung cancer	5.48e-05	0.000563	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—AVP—lung cancer	5.47e-05	0.000562	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—ALB—lung cancer	5.44e-05	0.000559	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP1A1—lung cancer	5.44e-05	0.000558	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ERCC2—lung cancer	5.39e-05	0.000554	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ABCB1—lung cancer	5.3e-05	0.000544	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—AVP—lung cancer	5.24e-05	0.000538	CbGpPWpGaD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	5.15e-05	0.000529	CbGpPWpGaD
Cefazolin—ALB—Metabolism—COL4A3BP—lung cancer	5.1e-05	0.000523	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AZIN2—lung cancer	5.1e-05	0.000523	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ABCB1—lung cancer	5.08e-05	0.000521	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—SRC—lung cancer	5.04e-05	0.000517	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—VEGFA—lung cancer	5.01e-05	0.000514	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—FGR—lung cancer	5e-05	0.000514	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL6—lung cancer	4.96e-05	0.00051	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—lung cancer	4.91e-05	0.000504	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MMP1—lung cancer	4.84e-05	0.000497	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—lung cancer	4.77e-05	0.00049	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	4.75e-05	0.000488	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GNG11—lung cancer	4.73e-05	0.000486	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—AVP—lung cancer	4.67e-05	0.000479	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—APOA1—lung cancer	4.66e-05	0.000479	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—CREBBP—lung cancer	4.64e-05	0.000477	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—MAPK3—lung cancer	4.64e-05	0.000477	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—APOA1—lung cancer	4.63e-05	0.000476	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	4.6e-05	0.000472	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—AVP—lung cancer	4.56e-05	0.000469	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PPIA—lung cancer	4.54e-05	0.000466	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCC3—lung cancer	4.52e-05	0.000464	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ALDOA—lung cancer	4.5e-05	0.000462	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VEGFC—lung cancer	4.5e-05	0.000462	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ABCB1—lung cancer	4.42e-05	0.000454	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TP53—lung cancer	4.41e-05	0.000453	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ALB—lung cancer	4.35e-05	0.000446	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ATP5H—lung cancer	4.33e-05	0.000445	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CG—lung cancer	4.26e-05	0.000437	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CG—lung cancer	4.23e-05	0.000434	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—APOA1—lung cancer	4.18e-05	0.000429	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—EGF—lung cancer	4.18e-05	0.000429	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PPP2R1B—lung cancer	4.15e-05	0.000426	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—GNG11—lung cancer	4.1e-05	0.00042	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—APOA1—lung cancer	4.07e-05	0.000418	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—POMC—lung cancer	4.05e-05	0.000416	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL6—lung cancer	4.04e-05	0.000415	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—APOA1—lung cancer	4.01e-05	0.000412	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	3.98e-05	0.000409	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TF—lung cancer	3.95e-05	0.000406	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CREBBP—lung cancer	3.95e-05	0.000405	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—RAF1—lung cancer	3.93e-05	0.000403	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CREBBP—lung cancer	3.92e-05	0.000403	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IRF1—lung cancer	3.87e-05	0.000397	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PLBD1—lung cancer	3.86e-05	0.000396	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	3.83e-05	0.000393	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.8e-05	0.00039	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CD—lung cancer	3.74e-05	0.000384	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CD—lung cancer	3.72e-05	0.000382	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CG—lung cancer	3.71e-05	0.000381	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALB—lung cancer	3.7e-05	0.000379	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ADCY1—lung cancer	3.68e-05	0.000378	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCG2—lung cancer	3.68e-05	0.000378	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ALB—lung cancer	3.67e-05	0.000377	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—EGF—lung cancer	3.67e-05	0.000377	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—CREBBP—lung cancer	3.54e-05	0.000363	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HSD17B10—lung cancer	3.53e-05	0.000363	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—APP—lung cancer	3.52e-05	0.000362	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—APOA1—lung cancer	3.49e-05	0.000358	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—TF—lung cancer	3.42e-05	0.000351	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—CREBBP—lung cancer	3.39e-05	0.000348	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—RAF1—lung cancer	3.32e-05	0.000341	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ALB—lung cancer	3.31e-05	0.00034	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CKB—lung cancer	3.28e-05	0.000337	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CD—lung cancer	3.26e-05	0.000335	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CB—lung cancer	3.26e-05	0.000335	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CB—lung cancer	3.24e-05	0.000333	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTGS2—lung cancer	3.23e-05	0.000332	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL6—lung cancer	3.21e-05	0.000329	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ALB—lung cancer	3.18e-05	0.000326	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—AKT1—lung cancer	3.13e-05	0.000321	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CNDP2—lung cancer	3.09e-05	0.000317	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTM2—lung cancer	3.09e-05	0.000317	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTMR3—lung cancer	3e-05	0.000308	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—RAF1—lung cancer	3e-05	0.000308	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IL2—lung cancer	2.98e-05	0.000306	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	2.95e-05	0.000303	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PGAM1—lung cancer	2.93e-05	0.0003	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—RAF1—lung cancer	2.91e-05	0.000299	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—RAF1—lung cancer	2.87e-05	0.000295	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	2.84e-05	0.000292	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTEN—lung cancer	2.82e-05	0.00029	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ITGB1—lung cancer	2.82e-05	0.000289	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2A7—lung cancer	2.79e-05	0.000287	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	2.77e-05	0.000284	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SDC4—lung cancer	2.73e-05	0.00028	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—EP300—lung cancer	2.69e-05	0.000276	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—EP300—lung cancer	2.67e-05	0.000274	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IL2—lung cancer	2.61e-05	0.000268	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SRC—lung cancer	2.6e-05	0.000267	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—VEGFA—lung cancer	2.53e-05	0.00026	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	2.5e-05	0.000257	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NRAS—lung cancer	2.5e-05	0.000257	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA3—lung cancer	2.49e-05	0.000255	CbGpPWpGaD
Cefazolin—ALB—Metabolism—RRM1—lung cancer	2.49e-05	0.000255	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MAPK3—lung cancer	2.39e-05	0.000246	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—AVP—lung cancer	2.37e-05	0.000244	CbGpPWpGaD
Cefazolin—ALB—Metabolism—B4GALT5—lung cancer	2.34e-05	0.00024	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ABCB1—lung cancer	2.3e-05	0.000236	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SRC—lung cancer	2.28e-05	0.000234	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA4—lung cancer	2.28e-05	0.000234	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.22e-05	0.000228	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—VEGFA—lung cancer	2.22e-05	0.000228	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA2—lung cancer	2.22e-05	0.000228	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MMP1—lung cancer	2.19e-05	0.000225	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—KRAS—lung cancer	2.15e-05	0.000221	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTA1—lung cancer	2.14e-05	0.00022	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ABCC3—lung cancer	2.12e-05	0.000217	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—MAPK3—lung cancer	2.1e-05	0.000216	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—APOA1—lung cancer	2.1e-05	0.000215	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKR1C1—lung cancer	2.05e-05	0.00021	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CA—lung cancer	1.99e-05	0.000204	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UGT1A1—lung cancer	1.99e-05	0.000204	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CA—lung cancer	1.98e-05	0.000203	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GNG11—lung cancer	1.92e-05	0.000197	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CG—lung cancer	1.91e-05	0.000196	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TP53—lung cancer	1.91e-05	0.000196	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.91e-05	0.000196	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—EGF—lung cancer	1.89e-05	0.000194	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HRAS—lung cancer	1.83e-05	0.000188	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALDOA—lung cancer	1.83e-05	0.000188	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	1.81e-05	0.000186	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CREBBP—lung cancer	1.77e-05	0.000182	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOA3—lung cancer	1.77e-05	0.000182	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.74e-05	0.000179	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	1.73e-05	0.000178	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ADCY1—lung cancer	1.72e-05	0.000177	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ABCG2—lung cancer	1.72e-05	0.000177	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HPGDS—lung cancer	1.69e-05	0.000174	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ENO2—lung cancer	1.69e-05	0.000174	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CD—lung cancer	1.68e-05	0.000173	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPP2R1B—lung cancer	1.68e-05	0.000173	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.66e-05	0.00017	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTT1—lung cancer	1.64e-05	0.000168	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—AKT1—lung cancer	1.63e-05	0.000167	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2A6—lung cancer	1.62e-05	0.000166	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GCLC—lung cancer	1.62e-05	0.000166	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.62e-05	0.000166	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT1—lung cancer	1.61e-05	0.000166	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ENO1—lung cancer	1.54e-05	0.000158	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	1.54e-05	0.000158	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.53e-05	0.000157	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RAF1—lung cancer	1.5e-05	0.000154	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CB—lung cancer	1.47e-05	0.000151	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	1.42e-05	0.000145	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2E1—lung cancer	1.38e-05	0.000142	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NQO1—lung cancer	1.36e-05	0.00014	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IL2—lung cancer	1.35e-05	0.000138	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.33e-05	0.000137	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.32e-05	0.000136	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	1.3e-05	0.000133	CbGpPWpGaD
Cefazolin—ALB—Metabolism—STK11—lung cancer	1.23e-05	0.000126	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—EP300—lung cancer	1.21e-05	0.000124	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SRC—lung cancer	1.18e-05	0.000121	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.15e-05	0.000118	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VEGFA—lung cancer	1.14e-05	0.000118	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTP1—lung cancer	1.14e-05	0.000117	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NRAS—lung cancer	1.13e-05	0.000116	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CAT—lung cancer	1.11e-05	0.000114	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.1e-05	0.000113	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MAPK3—lung cancer	1.08e-05	0.000111	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ABCB1—lung cancer	1.08e-05	0.000111	CbGpPWpGaD
Cefazolin—ALB—Metabolism—TYMS—lung cancer	1.06e-05	0.000109	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTM1—lung cancer	1.04e-05	0.000107	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP1A1—lung cancer	9.91e-06	0.000102	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ERCC2—lung cancer	9.82e-06	0.000101	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—KRAS—lung cancer	9.73e-06	9.99e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CA—lung cancer	8.94e-06	9.18e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TP53—lung cancer	8.65e-06	8.88e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—APOA1—lung cancer	8.5e-06	8.73e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HRAS—lung cancer	8.27e-06	8.49e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.14e-06	8.36e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CG—lung cancer	7.76e-06	7.97e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—POMC—lung cancer	7.39e-06	7.58e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT1—lung cancer	7.3e-06	7.5e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CREBBP—lung cancer	7.19e-06	7.39e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CD—lung cancer	6.82e-06	7e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CB—lung cancer	5.95e-06	6.1e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTGS2—lung cancer	5.89e-06	6.05e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTEN—lung cancer	5.14e-06	5.27e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—EP300—lung cancer	4.9e-06	5.03e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CA—lung cancer	3.62e-06	3.72e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKT1—lung cancer	2.96e-06	3.04e-05	CbGpPWpGaD
